tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719
Hong Kong Market

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

0719 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Shandong
Xinhua Pharmaceutical Company Limited Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0719 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:0719 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0719 Financial Forecast

0719 Earnings Forecast

Next quarter’s earnings estimate for 0719 is HK$0.28 with a range of HK$0.28 to HK$0.28. The previous quarter’s EPS was HK$0.06. 0719 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 0719 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0719 is HK$0.28 with a range of HK$0.28 to HK$0.28. The previous quarter’s EPS was HK$0.06. 0719 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 0719 has Performed in-line its overall industry.

0719 Sales Forecast

The previous quarter’s earnings for 0719 were HK$2.32B.
The previous quarter’s earnings for 0719 were HK$2.32B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Google Analyst forecast on HK:0719
TipRanks - Google
TipRanks - Google
HK$7.5
Hold
12.44%
Upside
Initiated
01/16/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on HK:0719
TipRanks - DeepSeek
TipRanks - DeepSeek
HK$7
Hold
4.95%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on HK:0719
TipRanks - xAI
TipRanks - xAI
HK$7.5
Hold
12.44%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on HK:0719
TipRanks - PerPlexity
TipRanks - PerPlexity
HK$8
Buy
19.94%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on HK:0719
TipRanks - Anthropic
TipRanks - Anthropic
HK$7
Hold
4.95%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on HK:0719
TipRanks - OpenAI
TipRanks - OpenAI
HK$7
Hold
4.95%
Upside
Downgraded
12/30/25
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - Google Analyst forecast on HK:0719
TipRanks - Google
TipRanks - Google
HK$7.5
Hold
12.44%
Upside
Initiated
01/16/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on HK:0719
TipRanks - DeepSeek
TipRanks - DeepSeek
HK$7
Hold
4.95%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on HK:0719
TipRanks - xAI
TipRanks - xAI
HK$7.5
Hold
12.44%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on HK:0719
TipRanks - PerPlexity
TipRanks - PerPlexity
HK$8
Buy
19.94%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on HK:0719
TipRanks - Anthropic
TipRanks - Anthropic
HK$7
Hold
4.95%
Upside
Initiated
01/14/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on HK:0719
TipRanks - OpenAI
TipRanks - OpenAI
HK$7
Hold
4.95%
Upside
Downgraded
12/30/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0719 Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 0719 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0719 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

0719 Stock Forecast FAQ

What is HK:0719’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:0719’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:0719, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Shandong Xinhua Pharmaceutical Company Limited Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Shandong Xinhua Pharmaceutical Company Limited Class H’s share price target?
      Currently, no data Available
      What do analysts say about Shandong Xinhua Pharmaceutical Company Limited Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Shandong Xinhua Pharmaceutical Company Limited Class H?
      To buy shares of HK:0719, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.